Pulmonary arterial haemodynamics and blood gas values of Thoroughbred racehorses with a history of epistaxis during a race.

This research article investigates the blood flow and oxygen levels in the pulmonary arteries of Thoroughbred racehorses that have suffered from nosebleeds during a race, concluding that lung problems may persist for up to two months after a nosebleed episode and suggesting further studies are needed to address race-induced lung damage.

Overview of the Research

In this research, ten Thoroughbred racehorses that had experienced epistaxis, also known as nosebleeds, during a race were examined. These horses were specifically chosen as nosebleeds in horses can often be a sign of underlying pulmonary issues. Blood flow and oxygen levels in the horse’s pulmonary arteries were measured and compared with a control group consisting of fourteen healthy Thoroughbred horses in training. Pulmonary arterial diastolic pressure and pulmonary arterial oxygen tension were the specific variables measured.

• Pulmonary arterial diastolic pressure (PADP) refers to the pressure in the pulmonary arteries when the heart is in a resting phase between beats.
• Pulmonary arterial oxygen tension (PaO2) indicates the amount of oxygen in the blood that’s in the pulmonary arteries.

Findings of the Study

The findings showed significant variation between the two groups. The horses that had suffered from epistaxis had higher levels of PADP and lower levels of PaO2 compared to the healthy Thoroughbreds in the control group. This suggests that horses which experienced epistaxis during a race may have persistent pulmonary dysfunction up to two months after the episode.

Implications of the Study

The researchers concluded that there is a need for further pulmonary function studies to be conducted before and after racing to better understand and resolve the issues concerning exercise-induced pulmonary haemorrhage. This could potentially lead to improved health and performance in Thoroughbred racehorses, as well as an overall decrease in the occurrence of epistaxis and other signs of pulmonary dysfunction during races. Furthermore, these findings could potentially have implications in the broader equine industry, contributing to our understanding of cardiovascular health in horses.